Mullokandov Eduard, Gejerman Glen
Department of Radiation Oncology, Hackensack University Medical Center, Hackensack, NJ, USA.
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1063-71. doi: 10.1016/j.ijrobp.2003.08.020.
As prostate high-dose-rate (HDR) brachytherapy becomes more prevalent, varying amounts of catheter displacement have been noted. To investigate the constancy of catheter position and its impact on dose distribution, we analyzed serial dosimetric CT scans.
The data from 50 patients were analyzed. During initial CT treatment planning, transverse images of the implant volume were collected, and all structures were digitized into the Nucletron Brachytherapy Planning System. Digitally reconstructed radiographs were generated with rendering of the catheter tips, ischial tuberosity, and perineal template. The distance from each catheter tip to the template and to the ischial tuberosity was measured. The distance between the ischial tuberosity and the template was similarly measured. A second CT set was obtained at different intervals and compared with the first measurement to assess catheter and/or template movement. In 10 patients, the second CT set was obtained before the third fraction in both 2-mm and 5-mm slice sequences, and the latter was used to re-create the HDR plan.
Although no interfraction catheter movement relative to the template was found, the template-catheter unit moved in a caudal direction between HDR fractions. The amount of displacement was time dependent: 2 mm before the second fraction, 8 mm before the third, and 10 mm before the fourth. When comparing the first HDR treatment with the third, median decreases in the following dosimetric parameters were noted: dose to 90% of the prostate volume, 35% (r = 0-60); minimal dose to the base, 35% (r = 17-65); and maximal dose to 1 cm(3), 13% (r = 3-19%).
The interstitial catheters did not slip within the template and were not caudally displaced independently but rather in conjunction with the template. The displacement occurred in a time-dependent fashion, and, without redress, significant dosimetric changes are encountered by the third fraction.
随着前列腺高剂量率(HDR)近距离放射治疗越来越普遍,已注意到导管移位量各不相同。为了研究导管位置的稳定性及其对剂量分布的影响,我们分析了系列剂量学CT扫描。
分析了50例患者的数据。在初始CT治疗计划期间,收集植入体积的横向图像,并将所有结构数字化到Nucletron近距离放射治疗计划系统中。通过导管尖端、坐骨结节和会阴模板的渲染生成数字重建射线照片。测量每个导管尖端到模板和坐骨结节的距离。同样测量坐骨结节和模板之间的距离。在不同间隔获得第二组CT并与第一次测量进行比较,以评估导管和/或模板的移动。在10例患者中,在第二次分次治疗前以2毫米和5毫米切片序列获得第二组CT,后者用于重新创建HDR计划。
虽然未发现分次间导管相对于模板的移动,但模板-导管单元在HDR分次之间向尾侧移动。移位量与时间有关:第二次分次前为2毫米,第三次前为8毫米,第四次前为10毫米。将第一次HDR治疗与第三次治疗进行比较时,注意到以下剂量学参数的中位数下降:前列腺体积90%的剂量,35%(r = 0 - 60);底部最小剂量,35%(r = 17 - 65);1立方厘米最大剂量,13%(r = 3 - 19%)。
间质导管未在模板内滑动,也未独立向尾侧移位,而是与模板一起移位。移位以时间依赖的方式发生,并且如果不进行纠正,到第三次分次时会出现显著的剂量学变化。